New search Hide text from Guidelines
B BLOOD AND BLOOD FORMING ORGANSB02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS
The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.). |
B02BD Blood coagulation factors
This group comprises all blood coagulation factors, thrombin etc., incl. preparations for local use, and their combinations. Gene therapy products replacing coagulation factors are also classified in this group.
For systemic formulations of fibrinogen (factor I), see - B02BB - Fibrinogen.
Prothrombin complexes containg three or all four factors are classified in B02BD01 coagulation factor IX, II, VII and X.
Both human derived and recombinant factor VIII and factor IX products will be classified in B02BD02 - coagulation factor VIII and B02BD04 - coagulation factor IX, respectively.
No DDDs are established for blood coagulation factors. The use of blood coagulation factors could be measured in blood factor units (IU). |
ATC code | Name | DDD | U | Adm.R | Note |
B02BD04 | coagulation factor IX |
Last updated: 2024-01-26